Drug intelligence / Profile preview

human umbilical cord mesenchymal stem cells (Beijing Tuohua Weiye)

Development stage: Unknown
Lead developer: Beijing Tuohua Weiye Biotechnology
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous

Overview

Human umbilical cord mesenchymal stem cells (hUC-MSCs) developed by Beijing Tuohua Weiye Biotechnology Co., Ltd. is an investigational cell therapy for the treatment of decompensated hepatitis B cirrhosis. These cells are derived from human umbilical cord tissue and are typically administered via intravenous infusion. The therapeutic mechanism involves the immunomodulatory and anti-inflammatory properties of mesenchymal stem cells, which aim to improve liver function, reduce inflammation, and potentially reverse liver fibrosis by interacting with hepatic stellate cells and the liver microenvironment. A Phase I/II clinical trial has been initiated to evaluate the safety, tolerability, and preliminary efficacy of this treatment in patients with HBV-related decompensated liver cirrhosis.

Other names: hUC-MSCHuman Umbilical Cord Mesenchymal Stem Cell Injection

Beyond the preview

Go deeper on human umbilical cord mesenchymal stem cells (Beijing Tuohua Weiye).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on human umbilical cord mesenchymal stem cells (Beijing Tuohua Weiye).

Explore the full profile